1. Home
  2. COGT vs IE Comparison

COGT vs IE Comparison

Compare COGT & IE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COGT
  • IE
  • Stock Information
  • Founded
  • COGT 2014
  • IE 2020
  • Country
  • COGT United States
  • IE United States
  • Employees
  • COGT N/A
  • IE N/A
  • Industry
  • COGT Biotechnology: Pharmaceutical Preparations
  • IE Metal Mining
  • Sector
  • COGT Health Care
  • IE Basic Materials
  • Exchange
  • COGT Nasdaq
  • IE Nasdaq
  • Market Cap
  • COGT 1.1B
  • IE 1.2B
  • IPO Year
  • COGT 2018
  • IE 2022
  • Fundamental
  • Price
  • COGT $12.36
  • IE $9.02
  • Analyst Decision
  • COGT Strong Buy
  • IE Strong Buy
  • Analyst Count
  • COGT 11
  • IE 3
  • Target Price
  • COGT $21.20
  • IE $12.67
  • AVG Volume (30 Days)
  • COGT 1.5M
  • IE 991.6K
  • Earning Date
  • COGT 11-11-2025
  • IE 11-07-2025
  • Dividend Yield
  • COGT N/A
  • IE N/A
  • EPS Growth
  • COGT N/A
  • IE N/A
  • EPS
  • COGT N/A
  • IE N/A
  • Revenue
  • COGT N/A
  • IE $3,806,000.00
  • Revenue This Year
  • COGT N/A
  • IE $12.72
  • Revenue Next Year
  • COGT N/A
  • IE $18.13
  • P/E Ratio
  • COGT N/A
  • IE N/A
  • Revenue Growth
  • COGT N/A
  • IE 35.54
  • 52 Week Low
  • COGT $3.72
  • IE $4.50
  • 52 Week High
  • COGT $13.50
  • IE $13.25
  • Technical
  • Relative Strength Index (RSI)
  • COGT 52.66
  • IE 47.63
  • Support Level
  • COGT $12.28
  • IE $8.55
  • Resistance Level
  • COGT $13.13
  • IE $9.24
  • Average True Range (ATR)
  • COGT 0.52
  • IE 0.34
  • MACD
  • COGT -0.08
  • IE 0.06
  • Stochastic Oscillator
  • COGT 30.06
  • IE 67.10

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

About IE Ivanhoe Electric Inc.

Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.

Share on Social Networks: